PFE

Pfizer's Dividend Faces Big Questions. Here Are 3 Reasons It Should Survive.

The Zacks Analyst Blog Highlights Pfizer, Novartis, Candel and Janux

What Is Pfizer (PFE) Really Getting From Its New ADC Licensing Deal?

Pfizer (PFE), Valneva (VALN) Lyme Vaccine Moves to EMA Review Despite Phase 3 Caveat

Pfizer Says Major Headwinds Are Easing as Pipeline, Obesity Plans Take Center Stage

Can Pfizer Overcome Its COVID and Patent Cliff Headwinds?

How Concerned Should Income Investors Be About Pfizer's Dividend?

Pfizer Stock Or Zoetis: Is The Comeback Worth Paying Up For?

Pfizer Stock: Firing On All Cylinders (NYSE:PFE)

Jim Cramer Picks J&J (JNJ) Over Eli Lilly (LLY) and Pfizer (PFE) Among These Healthcare Stocks

Pfizer Stock Rises Almost 9% in 3 Months: Time to Buy, Hold or Exit?

Why Pfizer Stock Was so Healthy in August

Move Aside, Pfizer: This Stock Is the Smarter Dividend Buy Right Now

Forget the Dividend. This Could Be the Real Reason to Buy Pfizer Stock Now

This Is What I'd Do With Pfizer Stock Right Now